BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21928324)

  • 1. Arf6 promotes cell proliferation via the PLD-mTORC1 and p38MAPK pathways.
    Knizhnik AV; Kovaleva OV; Komelkov AV; Trukhanova LS; Rybko VA; Zborovskaya IB; Tchevkina EM
    J Cell Biochem; 2012 Jan; 113(1):360-71. PubMed ID: 21928324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
    Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
    Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and regulation of phospholipase D2 by ARF6.
    Hiroyama M; Exton JH
    J Cell Biochem; 2005 May; 95(1):149-64. PubMed ID: 15759270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway.
    Tague SE; Muralidharan V; D'Souza-Schorey C
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9671-6. PubMed ID: 15210957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.
    Li M; Ng SS; Wang J; Lai L; Leung SY; Franco M; Peng Y; He ML; Kung HF; Lin MC
    Cancer Res; 2006 Feb; 66(3):1583-90. PubMed ID: 16452216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
    Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the role of ADP-ribosylation factor 6 in tumor cell invasion and extracellular signal-regulated kinase activation.
    Hoover H; Muralidharan-Chari V; Tague S; D'Souza-Schorey C
    Methods Enzymol; 2005; 404():134-47. PubMed ID: 16413265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growing importance of mTORC1-S6K1 signaling in kidney.
    Siroky BJ; Bitzer M
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F583-4. PubMed ID: 19570879
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A; Tee AR; Taylor PM; Proud CG
    Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
    Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytohesin-1 regulates the Arf6-phospholipase D signaling axis in human neutrophils: impact on superoxide anion production and secretion.
    El Azreq MA; Garceau V; Harbour D; Pivot-Pajot C; Bourgoin SG
    J Immunol; 2010 Jan; 184(2):637-49. PubMed ID: 20018626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
    MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
    Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling mechanisms of inhibition of phospholipase D activation by CHS-111 in formyl peptide-stimulated neutrophils.
    Chang LC; Huang TH; Chang CS; Tsai YR; Lin RH; Lee PW; Hsu MF; Huang LJ; Wang JP
    Biochem Pharmacol; 2011 Jan; 81(2):269-78. PubMed ID: 20965153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
    J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction pathways leading to increased eIF4E phosphorylation caused by oxidative stress.
    Duncan RF; Peterson H; Sevanian A
    Free Radic Biol Med; 2005 Mar; 38(5):631-43. PubMed ID: 15683719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the roles of ADP-ribosylation factors and phospholipase D in phorbol ester-induced membrane ruffling.
    Hiroyama M; Exton JH
    J Cell Physiol; 2005 Feb; 202(2):608-22. PubMed ID: 15389577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
    Kim MS; Lee EJ; Kim HR; Moon A
    Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of Arf6 in cancer cell invasion, metastasis and proliferation.
    Li R; Peng C; Zhang X; Wu Y; Pan S; Xiao Y
    Life Sci; 2017 Aug; 182():80-84. PubMed ID: 28625359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide siRNA screen in mammalian cells for regulators of S6 phosphorylation.
    Papageorgiou A; Rapley J; Mesirov JP; Tamayo P; Avruch J
    PLoS One; 2015; 10(3):e0116096. PubMed ID: 25790369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.